triamcinolone has been researched along with albuterol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Baker, MJ; Cockcroft, DW; Habbick, B; McNutt, M | 1 |
| Fox, S; Lin, RY; Newman, TG; Sauter, D; Sirleaf, J; Tavakol, M; Walters, J | 1 |
| Boushey, HA; Chinchilli, VM; Craig, TJ; Deykin, A; DiMango, E; Fahy, JV; Israel, E; Kraft, M; Lazarus, SC; Lehman, E; Lemanske, RF; Leone, F; Liu, W; Martin, RJ; Peters, SP; Sorkness, CA; Szefler, SJ; Wechsler, ME | 1 |
| Bascom, R; Chinchilli, VM; Craig, TJ; Duan, Y; Lazarus, SC; Lehman, EB; Liao, D; Lin, HM; Qian, Z; Shah, N; Stewart, WF; Wilson, WE | 1 |
| Marchand, E | 1 |
| Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B | 1 |
2 review(s) available for triamcinolone and albuterol
| Article | Year |
|---|---|
[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluticasone; Humans; Ipratropium; Long-Term Care; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide; Triamcinolone | 2010 |
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone | 2015 |
1 trial(s) available for triamcinolone and albuterol
| Article | Year |
|---|---|
beta-Adrenergic receptor polymorphisms and response to salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Drug Therapy, Combination; Female; Genotype; Glucocorticoids; Humans; Male; Polymorphism, Genetic; Receptors, Adrenergic, beta; Salmeterol Xinafoate; Triamcinolone | 2006 |
9 other study(ies) available for triamcinolone and albuterol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.
Topics: Administration, Inhalation; Administration, Topical; Adolescent; Adrenergic beta-Agonists; Adult; Aerosols; Albuterol; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Drug Prescriptions; Drug Utilization Review; Fenoterol; Fluocinolone Acetonide; Glucocorticoids; Humans; Isoproterenol; Metaproterenol; Middle Aged; Pregnenediones; Procaterol; Saskatchewan; Triamcinolone | 1995 |
Association between reported use of inhaled triamcinolone and differential short-term responses to aerosolized albuterol in asthmatics in an emergency department setting.
Topics: Acute Disease; Administration, Inhalation; Adult; Aerosols; Albuterol; Asthma; Emergency Service, Hospital; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Stimulation, Chemical; Treatment Outcome; Triamcinolone; Vital Capacity | 1994 |
Associations between air pollution and peak expiratory flow among patients with persistent asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Air; Air Pollutants; Albuterol; Asthma; Child; Environmental Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Nitric Oxide; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Sulfur Dioxide; Triamcinolone; Urban Health | 2009 |
Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.
Topics: Air Pollutants; Air Pollution; Albuterol; Anti-Asthmatic Agents; Asthma; Atmosphere; Bronchodilator Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Ipratropium; Metaproterenol; Nebulizers and Vaporizers; Ozone; Pulmonary Disease, Chronic Obstructive; Triamcinolone; United States | 2010 |